Financhill
Back

Kaival Brands Innovations Group Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
19

KAVL
Kaival Brands Innovations Group

Last Price:
$0.57
Seasonality Move:
668.09%
Buy
61

ALNY
Alnylam Pharmaceuticals

Last Price:
$283.34
Seasonality Move:
3.3%
Sell
19
Kaival Brands Innovations Group (KAVL) is a Sell

Is Kaival Brands Innovations Group a Buy, Sell or Hold?

  • The current Kaival Brands Innovations Group [KAVL] share price is $0.57. The Score for KAVL is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • KAVL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
61
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $283.34. The Score for ALNY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

KAVL Stock Price Chart

What is Kaival Brands Innovations Group's stock price today?

  • The Kaival Brands Innovations Group share price today is $0.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KAVL is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $283.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

KAVL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 28.89 Sell
Chaikin Money Flow: 79059 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.62 - 0.9) Sell
Bollinger Bands (100): (0.71 - 1.15) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.81 Buy
Relative Strength Index (14 RSI): 68.89 Buy
Chaikin Money Flow: 1798941 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (239.98 - 259.48) Buy
Bollinger Bands (100): (240.26 - 271.94) Buy

KAVL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.6 Sell
20-day SMA: 0.7 Sell
50-day SMA: 1 Sell
200-day SMA: 1.04 Sell
8-day EMA: 0.61 Sell
20-day EMA: 0.72 Sell
50-day EMA: 0.87 Sell
200-day EMA: 1.61 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 251.71 Buy
20-day SMA: 247.77 Buy
50-day SMA: 256.39 Buy
200-day SMA: 250.79 Buy
8-day EMA: 256.23 Buy
20-day EMA: 252.43 Buy
50-day EMA: 253.95 Buy
200-day EMA: 242.96 Buy

Kaival Brands Innovations Group Earnings Growth & KAVL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $0.95 per share, and an increase next year of $2.74 per share.

Kaival Brands Innovations Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):